Medical versus surgical treatment of first trimester spontaneous abortion: A cost-minimization analysis (vol 14, e0210449, 2019)

被引：0
|
作者：
Cubo, A. M.
Soto, Z. M.
Haro-Perez, A.
Hernandez, Hernandez M. E.
Doyague, M. J.
Sayagues, J. M.
机构：
来源：
PLOS ONE | 2019年 / 14卷 / 03期
关键词：
D O I：
10.1371/journal.pone.0214707
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 16 条
  • [1] Medical versus surgical treatment of first trimester spontaneous abortion: A cost-minimization analysis
    Cubo Nava, Ana
    Soto Pino, Zandra M.
    Haro Perez, Ana M.
    Hernandez Hernandez, M. Estrella
    Doyague Sanchez, M. Jose
    Sayagues Manzano, Jose M.
    [J]. PLOS ONE, 2019, 14 (01):
  • [2] Medical versus Surgical Abortion Methods for Pregnancy in China: A Cost-Minimization Analysis
    Xia, Wei
    She, Shouzhang
    Lam, Tai Hing
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2011, 72 (04) : 257 - 263
  • [3] Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis
    You, JHS
    Chung, TKH
    [J]. HUMAN REPRODUCTION, 2005, 20 (10) : 2873 - 2878
  • [4] COST-MINIMIZATION ANALYSIS OF XELOX VERSUS FOLFOX-6 IN THE FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER IN BRAZIL
    Caponero, R.
    Saggia, M. G.
    Nasciben, V. D.
    Santos, E. A.
    Stefani, S.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A474 - A475
  • [5] Cost Analysis of Surgical and Medical Uterine Evacuation Methods for First-Trimester Abortion Used in Public Hospitals in Mexico
    Eduardo Sanchez-Morales, Jorge
    Luis Rodriguez-Contreras, Jose
    Ruiz-Lara, Leslie
    Ochoa-Torres, Beatriz
    Zaragoza, Mara
    Padilla-Zuniga, Karen
    [J]. HEALTH SERVICES INSIGHTS, 2022, 15
  • [6] Bevacizumab plus Interferon-α versus Sunitinib for First-Line Treatment of Renal Cell Carcinoma in ItalyA Cost-Minimization Analysis
    Roberto Ravasio
    Cinzia Ortega
    Roberto Sabbatini
    Camillo Porta
    [J]. Clinical Drug Investigation, 2011, 31 : 507 - 517
  • [7] Bevacizumab plus Interferon-α versus Sunitinib for First-Line Treatment of Renal Cell Carcinoma in Italy A Cost-Minimization Analysis
    Ravasio, Roberto
    Ortega, Cinzia
    Sabbatini, Roberto
    Porta, Camillo
    [J]. CLINICAL DRUG INVESTIGATION, 2011, 31 (07) : 507 - 517
  • [8] COST-MINIMIZATION ANALYSIS OF XELOX VERSUS FOLFOX-6 IN THE FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER, ACCORDING TO THE RECOMMENDED BRAZILIAN GUIDELINES FOR HTA
    Caponero, R.
    Saggia, M. G.
    Nasciben, V. D.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 130 - 131
  • [9] COST-MINIMIZATION ANALYSIS OF BEVACIZUMAB VERSUS CETUXIMAB IN FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER IN KRAS WILD-TYPE PATIENTS IN THE SUPPLEMENTARY HEALTH CARE SYSTEM IN BRAZIL
    Tsuchiya, C. T.
    Kim, H. S. J.
    Maximo, M. F. M.
    Ramos, L. A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A641 - A641
  • [10] A META-ANALYSIS AND COST-MINIMIZATION ANALYSIS OF OXALIPLATIN-BASED CHEMOTHERAPY VERSUS IRINOTECAN-BASED CHEMOTHERAPY WITH TARGETED MOLECULAR AGENTS IN THE FIRST-LINE TREATMENT OF METASTATIC ADVANCED COLORECTAL CANCER IN CHINA
    Zhang, X.
    Su, W.
    Lin, Z.
    Bao, T.
    Jian, Y.
    Xuan, J.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S120 - S120
12